Search Results - "Anderson, Christen M"

Refine Results
  1. 1

    Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study by O'Neil, Patrick M., Smith, Steven R., Weissman, Neil J., Fidler, Meredith C., Sanchez, Matilde, Zhang, Jinkun, Raether, Brian, Anderson, Christen M., Shanahan, William R.

    Published in Obesity (Silver Spring, Md.) (01-07-2012)
    “…The BLOOM‐DM (Behavioral Modification and Lorcaserin for Obesity and Overweight Management in Diabetes Mellitus) study evaluated efficacy and safety of…”
    Get full text
    Journal Article
  2. 2

    A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial by Fidler, Meredith C, Sanchez, Matilde, Raether, Brian, Weissman, Neil J, Smith, Steven R, Shanahan, William R, Anderson, Christen M

    “…Context: Lorcaserin is a novel selective agonist of the serotonin 2C receptor. Objective: Our objective was to evaluate the effects of lorcaserin on body…”
    Get full text
    Journal Article
  3. 3

    Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies by Roth, Jonathan D, Roland, Barbara L, Cole, Rebecca L, Trevaskis, James L, Weyer, Christian, Koda, Joy E, Anderson, Christen M, Parkes, David G, Baron, Alain D

    “…Body weight is regulated by complex neurohormonal interactions between endocrine signals of long-term adiposity (e.g., leptin, a hypothalamic signal) and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management by Smith, Steven R, Weissman, Neil J, Anderson, Christen M, Sanchez, Matilde, Chuang, Emil, Stubbe, Scott, Bays, Harold, Shanahan, William R

    Published in The New England journal of medicine (15-07-2010)
    “…In this trial, obese or overweight adults were randomly assigned to receive the selective serotonin 2C receptor agonist lorcaserin or placebo for 52 weeks,…”
    Get full text
    Journal Article
  6. 6

    Lorcaserin, A 5-HT2C Receptor Agonist, Reduces Body Weight by Decreasing Energy Intake without Influencing Energy Expenditure by Martin, Corby K, Redman, Leanne M, Zhang, Jinkun, Sanchez, Matilde, Anderson, Christen M, Smith, Steven R, Ravussin, Eric

    “…Lorcaserin, a selective 5-HT2C receptor agonist, reduces body weight through its effects on food intake and appetite, not energy expenditure or substrate…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Biological activity of AC3174, a peptide analog of exendin-4 by Hargrove, Diane M., Kendall, Eric S., Reynolds, James M., Lwin, Aung N., Herich, John P., Smith, Pamela A., Gedulin, Bronislava R., Flanagan, Shawn D., Jodka, Carolyn M., Hoyt, Julie A., McCowen, Kevin M., Parkes, David G., Anderson, Christen M.

    Published in Regulatory peptides (07-06-2007)
    “…Exenatide, the active ingredient of BYETTA® (exenatide injection), is an incretin mimetic that has been developed for the treatment of patients with type 2…”
    Get full text
    Journal Article
  9. 9

    Lorcaserin (APD356), a Selective 5‐HT2C Agonist, Reduces Body Weight in Obese Men and Women by Smith, Steven R., Prosser, Warren A., Donahue, David J., Morgan, Michael E., Anderson, Christen M., Shanahan, William R.

    Published in Obesity (Silver Spring, Md.) (01-03-2009)
    “…Lorcaserin (APD356) is a potent, selective 5‐HT2C agonist with ∼15‐fold and 100‐fold selectivity vs. 5‐HT2A and 5‐HT2B receptors, respectively. This study…”
    Get full text
    Journal Article
  10. 10

    Antiobesity Effects of the β-Cell Hormone Amylin in Diet-Induced Obese Rats: Effects on Food Intake, Body Weight, Composition, Energy Expenditure, and Gene Expression by Roth, Jonathan D, Hughes, Heather, Kendall, Eric, Baron, Alain D, Anderson, Christen M

    Published in Endocrinology (Philadelphia) (01-12-2006)
    “…Effects of amylin and pair feeding (PF) on body weight and metabolic parameters were characterized in diet-induced obesity-prone rats. Peripherally…”
    Get full text
    Journal Article
  11. 11

    Echocardiographic assessment of cardiac valvular regurgitation with lorcaserin from analysis of 3 phase 3 clinical trials by Weissman, Neil J, Sanchez, Matilde, Koch, Gary G, Smith, Steven R, Shanahan, William R, Anderson, Christen M

    Published in Circulation. Cardiovascular imaging (01-07-2013)
    “…Lorcaserin is a selective 5-HT2C agonist evaluated for weight management in clinical trials. Echocardiographic monitoring was conducted to test the hypothesis…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats by Roth, Jonathan D, Hughes, Heather, Coffey, Todd, Maier, Holly, Trevaskis, James L, Anderson, Christen M

    “…Amylin infusion reduces food intake and slows body weight gain in rodents. In obese male rats, amylin (but not pair feeding) caused a preferential reduction of…”
    Get more information
    Journal Article
  14. 14

    Lorcaserin (APD356), a Selective 5‐HT 2C Agonist, Reduces Body Weight in Obese Men and Women by Smith, Steven R., Prosser, Warren A., Donahue, David J., Morgan, Michael E., Anderson, Christen M., Shanahan, William R.

    Published in Obesity (Silver Spring, Md.) (06-09-2012)
    “…Lorcaserin (APD356) is a potent, selective 5‐HT 2C agonist with ∼15‐fold and 100‐fold selectivity vs. 5‐HT 2A and 5‐HT 2B receptors, respectively. This study…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Inhibition of mitochondrial Na(+) -Ca(2+) exchanger increases mitochondrial metabolism and potentiates glucose-stimulated insulin secretion in rat pancreatic islets by Lee, Bumsup, Miles, Philip D, Vargas, Leonardo, Peng Luan

    Published in Diabetes (New York, N.Y.) (01-04-2003)
    “…The mitochondrial Na(+)-Ca(2+) exchanger (mNCE) mediates efflux of Ca(2+) from mitochondria in exchange for influx of Na(+). We show that inhibition of the…”
    Get full text
    Journal Article
  17. 17

    Lorcaserin (APD356), a Selective 5-HT Agonist, Reduces Body Weight in Obese Men and Women by Smith, Steven R, Prosser, Warren A, Donahue, David J, Morgan, Michael E, Anderson, Christen M, Shanahan, William R

    Published in Obesity (Silver Spring, Md.) (01-03-2009)
    “…Lorcaserin (APD356) is a potent, selective 5-HT(2C) agonist with ~15-fold and 100-fold selectivity vs. 5-HT(2A) and 5-HT(2B) receptors, respectively. This…”
    Get full text
    Journal Article
  18. 18

    Regulation of steroidogenesis in rat Leydig cells in culture: effect of human chorionic gonadotropin and dibutyryl cyclic AMP on the synthesis of cholesterol side chain cleavage cytochrome P-450 and adrenodoxin by Anderson, C M, Mendelson, C R

    Published in Archives of biochemistry and biophysics (01-05-1985)
    “…Rat Leydig cells in primary culture were used as a model system to investigate the effects of human chorionic gonadotropin (hCG) and dibutyryl cyclic AMP…”
    Get more information
    Journal Article
  19. 19

    Pharmacokinetics and Tolerability of Lorcaserin in Special Populations: Elderly Patients and Patients with Renal or Hepatic Impairment by Christopher, Ronald J., PhD, DABT, Morgan, Michael E, Tang, Yong, Anderson, Christen, MD, PhD, Sanchez, Matilde, Shanahan, William

    Published in Clinical therapeutics (01-04-2017)
    “…Abstract Purpose To determine whether dosage adjustment is likely to be necessary for effective and well-tolerated use of a pharmaceutical agent, guidance…”
    Get full text
    Journal Article
  20. 20

    Antiobesity Effects of the {szligbeta}-Cell Hormone Amylin in Diet-Induced Obese Rats: Effects on Food Intake, Body Weight, Composition, Energy Expenditure, and Gene Expression by Roth, Jonathan D, Hughes, Heather, Kendall, Eric, Baron, Alain D, Anderson, Christen M

    Published in Endocrinology (Philadelphia) (01-12-2006)
    “…Effects of amylin and pair feeding (PF) on body weight and metabolic parameters were characterized in diet-induced obesity-prone rats. Peripherally…”
    Get full text
    Journal Article